Pharma Is Ready And Waiting For A Tax Holiday Under Trump

US biopharmas are holding billions in cash overseas to avoid paying America’s high corporate tax rate, so the prospect of a US tax holiday – or broad tax reform – will be welcomed by industry.

The last time the US granted a tax holiday on corporate cash held overseas was more than a decade ago, so the prospect of a Donald Trump presidency paving the way for billions of ex-US cash to be brought back into the country at a lower tax rate will be welcomed by industry.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Elections

More from Legislation